BACKGROUND AND OBJECTIVE: Bisphosphonate-associated osteonecrosis of the jaw (BONJ) is an emerging oral complication that occurs most commonly in the setting of high-dose bisphosphonate therapy for cancer. The purpose of this study was to estimate the health care-related costs associated with a diagnosis of BONJ in patients with cancer evaluated and managed at one tertiary oral medicine practice. METHODS: This was a retrospective electronic medical record review of cancer patients with BONJ. All health care-related resources were abstracted using a structured chart abstraction tool; data captured included medications, imaging studies, laboratory investigations, procedures, and visits. Standardized references were used to assign costs in 2010 US dollars. RESULTS: Ninety-two cancer patients with BONJ were identified who were followed for a median of 12 months. The median cost of a case of BONJ was $1667 (interquartile range from $976 to $3350). Medication costs comprised the majority (42%) of the total costs, followed by procedural interventions (22%), clinic visits (19.5%), and imaging studies (13.8%). Patient factors associated with higher median costs included a greater number of involved oral quadrants and more advanced BONJ stage. CONCLUSION: There are considerable costs associated with the diagnosis and management of BONJ in patients with cancer, with medications accounting for nearly half of resource expenditures.
BACKGROUND AND OBJECTIVE:Bisphosphonate-associated osteonecrosis of the jaw (BONJ) is an emerging oral complication that occurs most commonly in the setting of high-dose bisphosphonate therapy for cancer. The purpose of this study was to estimate the health care-related costs associated with a diagnosis of BONJ in patients with cancer evaluated and managed at one tertiary oral medicine practice. METHODS: This was a retrospective electronic medical record review of cancerpatients with BONJ. All health care-related resources were abstracted using a structured chart abstraction tool; data captured included medications, imaging studies, laboratory investigations, procedures, and visits. Standardized references were used to assign costs in 2010 US dollars. RESULTS: Ninety-two cancerpatients with BONJ were identified who were followed for a median of 12 months. The median cost of a case of BONJ was $1667 (interquartile range from $976 to $3350). Medication costs comprised the majority (42%) of the total costs, followed by procedural interventions (22%), clinic visits (19.5%), and imaging studies (13.8%). Patient factors associated with higher median costs included a greater number of involved oral quadrants and more advanced BONJ stage. CONCLUSION: There are considerable costs associated with the diagnosis and management of BONJ in patients with cancer, with medications accounting for nearly half of resource expenditures.
Authors: Jose V Bagan; Yolanda Jimenez; Judith Murillo; Sergio Hernandez; Rafael Poveda; José M Sanchis; José M Diaz; Crispian Scully Journal: Oral Oncol Date: 2005-11-04 Impact factor: 5.337
Authors: Salvatore Ruggiero; Julie Gralow; Robert E Marx; Ana O Hoff; Mark M Schubert; Joseph M Huryn; Bela Toth; Kathryn Damato; Vicente Valero Journal: J Oncol Pract Date: 2006-01 Impact factor: 3.840
Authors: Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra Journal: J Oral Maxillofac Surg Date: 2009-05 Impact factor: 1.895
Authors: Joan C Lo; Felice S O'Ryan; Nancy P Gordon; Jingrong Yang; Rita L Hui; Daniel Martin; Matthew Hutchinson; Phenius V Lathon; Gabriela Sanchez; Paula Silver; Malini Chandra; Carolyn A McCloskey; Judy A Staffa; Mary Willy; Joe V Selby; Alan S Go Journal: J Oral Maxillofac Surg Date: 2009-09-24 Impact factor: 1.895
Authors: Beatrice J Edwards; John W Hellstein; Peter L Jacobsen; Steven Kaltman; Angelo Mariotti; Cesar A Migliorati Journal: J Am Dent Assoc Date: 2008-12 Impact factor: 3.634
Authors: Aliya A Khan; George K B Sándor; Edward Dore; Archibald D Morrison; Mazen Alsahli; Faizan Amin; Edmund Peters; David A Hanley; Sultan R Chaudry; David W Dempster; Francis H Glorieux; Alan J Neville; Reena M Talwar; Cameron M Clokie; Majd Al Mardini; Terri Paul; Sundeep Khosla; Robert G Josse; Susan Sutherland; David K Lam; Robert P Carmichael; Nick Blanas; David Kendler; Steven Petak; Louis Georges St-Marie; Jacques Brown; A Wayne Evans; Lorena Rios; Juliet E Compston Journal: J Rheumatol Date: 2008-06-01 Impact factor: 4.666
Authors: David K Lam; George K B Sándor; Howard I Holmes; A Wayne Evans; Cameron M L Clokie Journal: J Can Dent Assoc Date: 2007-06 Impact factor: 1.316
Authors: Christian Thomas; Georg Bartsch; Christian Walter; Hendrik Borgmann; Maximilian Peter Brandt; Thomas Höfner; Axel Haferkamp; Igor Tsaur Journal: Dent J (Basel) Date: 2016-08-19